1.
Eye (Lond)
; 33(10): 1670-1672, 2019 10.
Article
in English
| MEDLINE
| ID: mdl-31114029
Subject(s)
Antineoplastic Agents, Immunological/adverse effects , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Immunotherapy/adverse effects , Melanoma/drug therapy , Panuveitis/chemically induced , Uveitis, Anterior/chemically induced , Aged , Antibodies, Monoclonal, Humanized/adverse effects , Electroretinography , Female , Humans , Incidence , Ipilimumab/adverse effects , Male , Melanoma/secondary , Nivolumab/adverse effects , Northern Ireland/epidemiology , Panuveitis/diagnostic imaging , Panuveitis/epidemiology , Panuveitis/physiopathology , Retina/physiopathology , Tomography, Optical Coherence , Uveitis, Anterior/diagnostic imaging , Uveitis, Anterior/epidemiology , Uveitis, Anterior/physiopathology , Visual Acuity/physiology
2.
BMJ
; 354: i3813, 2016 07 12.
Article
in English
| MEDLINE
| ID: mdl-27406811